Figure 1

Healthcare has reached a critical juncture. The World Economic Forum estimates that global medical costs will see double digit increases for the third consecutive year since 2023, with estimates suggesting an average rise of 10.4 percent worldwide in 20251 driven by factors including overwhelmed public healthcare systems and a rising demand for private healthcare.

Nov. 30, 2025 — Fujifilm Healthcare Americas Corp. has launched Synapse One, a comprehensive, tailor-made workflow solution designed for outpatient imaging needs, in North America*.

Dec,. 1, 2025 — Canon has announced that the U.S. Food and Drug Administration (FDA) has granted [510(k) clearance/PMA approval] for its Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, which follows a successful European launch in August. This next-generation Angio-CT hybrid one-suite solution (Alphenix 4D CT) represents Canon’s commitment to advancing interventional therapy with enhanced clinical workflows.

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end-to-end suite of modular, interoperable AI-powered applications that address real-world clinical needs across the breast cancer screening and detection pathways. Breast Suite builds on organic innovation and integrated technologies from iCAD to deliver a comprehensive suite of solutions.

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced that the FDA has approved an Investigational Device Exemption (IDE) application to initiate a pilot study for treating patients with locally recurrent prostate cancer using the Company’s Alpha DaRT technology.

Dec. 2, 2025 — At RSNA 2025, GE HealthCare showcased several innovations brought to life through an expanded collaboration with NVIDIA. This collaboration underscores GE HealthCare’s ongoing commitment to integrating advanced technologies that aim to transform healthcare delivery and improve patient care. The company is leveraging NVIDIA’s offerings and expertise in areas of physical AI, high performance computing and simulation, which has the potential to reduce manual tasks, increase patient comfort, and alleviate radiologist burnout through AI-powered assistance.

Dec. 1, 2025  — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio available through Precision Imaging Network, part of Microsoft for Healthcare. By integrating Transpara with Precision Imaging Network, ScreenPoint Medical expands how healthcare providers can access Breast AI tools to support workflow efficiency and clinical decision-making.

Dec. 1, 2025 – Zwanger-Pesiri Radiology, one of the most respected and technologically advanced outpatient radiology practices in the Northeast, has implemented Bone Suppression Imaging (BSI) technology from Konica Minolta Healthcare Americas, Inc., to support more precise visualization of pulmonary abnormalities on chest X-rays.

Nov. 26, 2025 — a2z Radiology AI has received U.S. FDA clearance for a2z-Unified-Triage, a single device that flags and prioritizes seven urgent findings on abdomen-pelvis CT scans simultaneously.

a2z is positioning itself as a leader in abdomen-pelvis AI. The company is bringing a first-of-its-kind capability to the U.S. market: a single system that triages seven urgent conditions on abdomen-pelvis CTs in one pass.

Dec. 1, 2025 — BioSked has announced a major expansion of its Momentum scheduling platform, introducing one of the first AI-driven solutions that plans radiology and teleradiology teams based on Relative Value Units (RVUs) and across multiple time zones. The company showcased Momentum at RSNA 2025 in Chicago.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now